The clinical and prognostic significance of erythrocyte sedimentation rate (ESR), serum interleukin-6 (IL-6) and acute phase protein levels in multiple myeloma
Authors:
- 24 January 2003
- journal article
- research article
- Published by Wiley in Clinical and Laboratory Haematology
- Vol. 25 (1) , 41-46
Abstract
Summary Interleukin‐6 (IL‐6) and acute phase proteins are commonly increased in patients with multiple myeloma. Several of these acute phase proteins are believed to predict prognosis and influence s...Keywords
This publication has 24 references indexed in Scilit:
- Serum interleukin‐6 (IL‐6) and interleukin‐4 (IL‐4) in patients with multiple myeloma (MM)British Journal of Haematology, 1996
- Serum immunoreactive interleukin‐6 and C‐reactive protein levels in patients with multiple myeloma at diagnosisBritish Journal of Haematology, 1994
- Acute phase proteins and prognosis in multiple myelomaBritish Journal of Haematology, 1993
- Tumor necrosis factor (TNF) inhibits interleukin (IL)-1 and/or IL-6 stimulated synthesis of C-reactive protein (CRP) and serum amyloid A (SAA) in primary cultures of human hepatocytesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1991
- Serum levels of interleukin-6 in multiple myeloma and other hematological disorders: correlation with disease activity and other prognostic parametersAnnals of Hematology, 1991
- The Use of a Commercially Available Immunoassay to Determine the Level of Interleukin-6 in the Serum of Patients with MyelomaLeukemia & Lymphoma, 1991
- Acute-phase response of human hepatocytes: Regulation of acute-phase protein synthesis by interleukin-6Hepatology, 1990
- Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias.Journal of Clinical Investigation, 1989
- Interleukin‐6 is the major regulator of acute phase protein synthesis in adult human hepatocytesFEBS Letters, 1989
- Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomasNature, 1988